Related Experiment Videos
Regulation of cell proliferation, apoptosis, and carcinogenesis by activin
Ye-Guang Chen1, Hannah M Lui, Shi-Lung Lin
1Division of Biomedical Sciences, University of California, Riverside, California 92521, USA.
Abstract:
The aim of this review is to provide insight into the molecular mechanisms by which activin A modulates cell proliferation, apoptosis, and carcinogenesis in vitro and in vivo. Activin A, a member of the TGFbeta superfamily, has various effects on diverse biological systems, including cell growth inhibition in many cell types. However, the mechanism(s) by which activin exerts its inhibitory effects are not yet understood. This review highlights activin's effects on activin receptors and signaling pathway, modulation of activin signaling, and regulation of cell proliferation and apoptosis by activin. Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and p21 and regulators of apoptosis such as p53 and members of the bcl-2 family. Aside from activin's inhibition of cell proliferation and enhancement of apoptosis, other newly developed methods for molecular studies of apoptosis by activin were briefly presented that support the role of activin as an inhibitor of carcinogenesis and cancer progression. These methods include subtractive hybridization based on covalent bonding, a simple and accurate means to determine molecular profile of as few as 20 cells based on an RNA-PCR approach, and a messenger RNA-antisense DNA interference phenomenon (D-RNAi), resulting in a long-term gene knockout effects.
Insights
Activin A, a TGFbeta superfamily member, inhibits cell proliferation and promotes apoptosis through molecular mechanisms involving cell cycle inhibitors and apoptosis regulators. This review explores its role in preventing carcinogenesis and cancer progression.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Activin A, a member of the TGFbeta superfamily, exhibits diverse biological effects, including cell growth inhibition.
- The precise molecular mechanisms underlying activin A's inhibitory actions on cell proliferation and apoptosis remain incompletely understood.
Purpose of the Study:
- To elucidate the molecular mechanisms of activin A's modulation of cell proliferation, apoptosis, and carcinogenesis.
- To review activin A's effects on its receptors, signaling pathways, and downstream targets.
- To highlight novel molecular methods for studying activin A-mediated apoptosis.
Main Methods:
- Review of existing literature on activin A signaling pathways.
- Analysis of activin A's impact on cell cycle inhibitors (p16, p21) and apoptosis regulators (p53, bcl-2 family).
- Brief presentation of advanced molecular techniques for apoptosis studies, including subtractive hybridization, RNA-PCR, and D-RNAi.
Main Results:
- Activin A influences cell proliferation and apoptosis through modulation of key regulatory proteins.
- Activin A signaling pathways are critical for its biological effects.
- Novel molecular techniques offer precise analysis of activin A's role in apoptosis.
Conclusions:
- Activin A acts as an inhibitor of cell proliferation and an enhancer of apoptosis.
- Activin A demonstrates potential as an inhibitor of carcinogenesis and cancer progression.
- Further research into activin A's molecular mechanisms and therapeutic applications is warranted.